Understanding how fentanyl and stimulants are used together by homeless individuals
A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness
This study is looking at how people who are homeless in New York City and San Francisco use fentanyl and stimulants together, and it aims to understand the risks involved and how homelessness affects their substance use, so we can improve support and treatment options for them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10590218 on NIH RePORTER |
What this research studies
This research investigates the patterns of fentanyl and stimulant use among people experiencing homelessness in New York City and San Francisco. By conducting interviews and focus groups over five years, the study aims to gather qualitative data on how these substances are used together and the associated risks. The research will also explore the impact of homelessness on substance use and the effectiveness of current overdose prevention and treatment strategies. This information could help inform better support and intervention programs for vulnerable populations.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing homelessness who use fentanyl and stimulants like cocaine or methamphetamine.
Not a fit: Patients who do not use fentanyl or stimulants, or who are not experiencing homelessness, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment and prevention strategies for individuals struggling with polysubstance use, ultimately reducing overdose deaths.
How similar studies have performed: While there is ongoing research into substance use among homeless populations, this specific focus on fentanyl-stimulant polysubstance use is relatively novel and has not been extensively studied.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Mcneil, Ryan — Yale University
- Study coordinator: Mcneil, Ryan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.